Free Trial

Bellevue Group AG Sells 8,831 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background

Bellevue Group AG cut its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 11.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,562 shares of the company's stock after selling 8,831 shares during the quarter. Bellevue Group AG owned approximately 0.12% of Molina Healthcare worth $23,279,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in MOH. Jupiter Asset Management Ltd. lifted its stake in shares of Molina Healthcare by 434.6% during the 2nd quarter. Jupiter Asset Management Ltd. now owns 185,606 shares of the company's stock worth $55,181,000 after purchasing an additional 150,890 shares during the period. AQR Capital Management LLC raised its position in Molina Healthcare by 36.2% in the second quarter. AQR Capital Management LLC now owns 463,537 shares of the company's stock valued at $137,810,000 after purchasing an additional 123,121 shares during the period. Renaissance Technologies LLC lifted its position in Molina Healthcare by 13.3% during the 2nd quarter. Renaissance Technologies LLC now owns 949,691 shares of the company's stock worth $282,343,000 after acquiring an additional 111,154 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Molina Healthcare by 22.0% in the second quarter. Dimensional Fund Advisors LP now owns 470,932 shares of the company's stock valued at $140,026,000 after purchasing an additional 84,929 shares during the period. Finally, Candriam S.C.A. grew its stake in shares of Molina Healthcare by 1,565.1% during the second quarter. Candriam S.C.A. now owns 71,285 shares of the company's stock valued at $21,192,000 after acquiring an additional 67,004 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

MOH has been the subject of a number of research analyst reports. Robert W. Baird dropped their price target on shares of Molina Healthcare from $405.00 to $331.00 and set an "outperform" rating for the company in a research note on Thursday, October 24th. StockNews.com upgraded Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, October 18th. Wells Fargo & Company upped their target price on shares of Molina Healthcare from $360.00 to $362.00 and gave the stock an "equal weight" rating in a research report on Monday, November 4th. Barclays lifted their price target on Molina Healthcare from $359.00 to $372.00 and gave the company an "equal weight" rating in a report on Friday, October 25th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $406.00 target price on shares of Molina Healthcare in a research note on Thursday, October 24th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $367.17.

Check Out Our Latest Stock Analysis on MOH

Molina Healthcare Price Performance

Shares of MOH traded up $1.30 during mid-day trading on Friday, hitting $297.90. The company's stock had a trading volume of 267,142 shares, compared to its average volume of 714,674. Molina Healthcare, Inc. has a fifty-two week low of $272.69 and a fifty-two week high of $423.92. The stock has a market capitalization of $17.04 billion, a price-to-earnings ratio of 15.13, a PEG ratio of 1.03 and a beta of 0.59. The firm has a 50-day moving average price of $317.40 and a 200 day moving average price of $322.00. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.54 and a quick ratio of 1.55.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.96 by $0.05. The company had revenue of $10.34 billion during the quarter, compared to the consensus estimate of $9.92 billion. Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. The firm's revenue was up 21.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.05 EPS. On average, research analysts predict that Molina Healthcare, Inc. will post 23.44 EPS for the current fiscal year.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

See Also

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad)

Should you invest $1,000 in Molina Healthcare right now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner

Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner

Amazon is set to continue its dominance in 2025, fueled by its robust e-commerce platform and the unmatched power of AWS in the data center space.

Related Videos

Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines